Illinois HB3472 mandates discussions about opioid risks before issuing prescriptions.
HB3472 amends the Illinois Food, Drug and Cosmetic Act to require health care practitioners to discuss the risks of opioid addiction and overdose with patients before issuing initial and third prescriptions. This includes the dangers of mixing opioids with alcohol, benzodiazepines, or other central nervous system depressants. The practitioner must also discuss alternative treatments and any additional risks. This discussion is not required for patients in active cancer treatment, hospice care, or long-term care facilities.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.